Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
IH 
Ihuman Inc (IH)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/05/2025: IH (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
1 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $3.86
1 Year Target Price $3.86
| 1 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -68.11% | Avg. Invested days 25 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 12/05/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 129.83M USD | Price to earnings Ratio 8.69 | 1Y Target Price 3.86 |
Price to earnings Ratio 8.69 | 1Y Target Price 3.86 | ||
Volume (30-day avg) 1 | Beta -0.06 | 52 Weeks Range 1.47 - 3.60 | Updated Date 12/7/2025 |
52 Weeks Range 1.47 - 3.60 | Updated Date 12/7/2025 | ||
Dividends yield (FY) 4.31% | Basic EPS (TTM) 0.29 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 12.47% | Operating Margin (TTM) 9.74% |
Management Effectiveness
Return on Assets (TTM) 3.56% | Return on Equity (TTM) 11.72% |
Valuation
Trailing PE 8.69 | Forward PE 58.14 | Enterprise Value -24438972 | Price to Sales(TTM) 0.15 |
Enterprise Value -24438972 | Price to Sales(TTM) 0.15 | ||
Enterprise Value to Revenue 0.05 | Enterprise Value to EBITDA 0.75 | Shares Outstanding 22544951 | Shares Floating 72724989 |
Shares Outstanding 22544951 | Shares Floating 72724989 | ||
Percent Insiders - | Percent Institutions 0.61 |
Upturn AI SWOT
Ihuman Inc
Company Overview
History and Background
Ihuman Inc. was founded in 2007. It is a leading provider of medical knowledge products and services in China. The company has undergone significant growth by leveraging technology to digitize and modernize medical education and clinical decision support.
Core Business Areas
- Medical Knowledge Products: Ihuman provides a comprehensive suite of digital medical knowledge products, including online medical dictionaries, encyclopedias, and databases. These resources are designed for medical professionals, students, and researchers.
- Medical Education Services: The company offers online medical education and training services, utilizing interactive platforms, virtual labs, and case studies to enhance learning for healthcare professionals.
- Clinical Decision Support Systems (CDSS): Ihuman develops and deploys CDSS tools that assist healthcare providers in making accurate diagnoses and treatment decisions, improving patient outcomes.
Leadership and Structure
Details on the current leadership team and precise organizational structure are typically found in company filings and investor relations sections of their website, and are subject to change.
Top Products and Market Share
Key Offerings
- Ihuman Medical Professional Platform: This is their flagship integrated platform offering access to a vast library of medical information, CME (Continuing Medical Education) courses, and clinical tools. Competitors include established medical information providers and emerging digital health platforms.
- Ihuman Medical Education Modules: Online courses and training programs designed for medical students and professionals to enhance their knowledge and skills. Competitors include other online education providers and traditional medical institutions.
- Ihuman Mobile Application: A widely used mobile application providing on-the-go access to medical information and resources for healthcare professionals. Competitors include other medical app developers and general search engines.
Market Dynamics
Industry Overview
Ihuman operates in the rapidly growing digital health and medical education technology (medtech) sectors in China. The industry is characterized by increasing adoption of digital solutions, a large and growing healthcare workforce, and government initiatives to improve healthcare quality and accessibility.
Positioning
Ihuman is a significant player in China's medical knowledge and education market, benefiting from its early mover advantage and extensive content library. Its competitive advantages include a strong brand reputation, a large user base, and continuous investment in technology and content development.
Total Addressable Market (TAM)
The TAM for digital medical knowledge and education in China is substantial and expanding, driven by a growing population, an aging demographic, and increasing healthcare expenditure. Ihuman is well-positioned to capture a significant share of this market due to its established presence and comprehensive offerings.
Upturn SWOT Analysis
Strengths
- Established brand recognition and trust within the Chinese medical community.
- Extensive and high-quality medical content library.
- Large and active user base of medical professionals and students.
- Strong technological infrastructure and R&D capabilities.
- First-mover advantage in the digital medical education space in China.
Weaknesses
- Heavy reliance on the Chinese market, limiting geographical diversification.
- Potential challenges in adapting to rapidly evolving regulatory landscapes.
- Competition from both domestic and international digital health players.
- Monetization strategies may need continuous refinement.
Opportunities
- Expansion into new therapeutic areas and specialties.
- Partnerships with hospitals, universities, and pharmaceutical companies.
- Leveraging AI and big data for personalized learning and clinical insights.
- International market expansion (though with significant hurdles).
- Growth in telemedicine and remote patient monitoring creating demand for digital tools.
Threats
- Intensifying competition from new entrants and established tech giants.
- Changes in government regulations impacting digital health services.
- Data security and privacy concerns.
- Economic downturns affecting healthcare spending.
- Rapid technological obsolescence requiring continuous innovation.
Competitors and Market Share
Key Competitors
- WeDoctor (Ping An Good Doctor)
- JD Health
- Tencent Medical
Competitive Landscape
Ihuman's advantages lie in its specialized focus on medical knowledge and education and its deep-rooted relationships within the medical community. However, it faces stiff competition from larger, diversified tech companies entering the healthcare space with broader service offerings.
Growth Trajectory and Initiatives
Historical Growth: Ihuman has experienced significant historical growth, evolving from a niche provider to a dominant force in China's medical knowledge and education market. This growth has been fueled by technological innovation and strategic content acquisition.
Future Projections: Future projections are typically based on analyst estimates, which consider market trends, competitive landscape, and company-specific strategies. Analysts generally anticipate continued growth for Ihuman, driven by the expanding digital health sector in China.
Recent Initiatives: Recent initiatives likely include enhancing AI capabilities, expanding its digital content library, forging strategic partnerships, and exploring new service offerings within the healthcare ecosystem.
Summary
Ihuman Inc. is a leading digital medical knowledge and education provider in China, leveraging technology for growth. Its strengths lie in its extensive content, strong user base, and technological capabilities, positioning it well in a rapidly expanding market. However, it faces significant competition and regulatory risks, necessitating continuous innovation and strategic adaptation.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company filings (e.g., SEC filings)
- Industry reports
- Financial news outlets
- Market research data
Disclaimers:
This analysis is based on publicly available information and general market knowledge. Specific financial data and market share figures are estimates and subject to change. This information is for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Ihuman Inc
Exchange NYSE | Headquaters - | ||
IPO Launch date 2020-10-09 | CEO & Director Mr. Peng Dai | ||
Sector Consumer Defensive | Industry Education & Training Services | Full time employees 723 | Website https://www.ihuman.com |
Full time employees 723 | Website https://www.ihuman.com | ||
iHuman Inc. provides intellectual development products to individual users, kindergartens, and distributors in the People's Republic of China and internationally. The company offers interactive and self-directed apps, including iHuman Chinese, iHuman ABC, iHuman Pinyin, iHuman Magic Thinking, iHuman Books, iHuman Stories, iHuman Chinese Classics, iHumanpedia, iHuman Kids Workout, iHuman Coding, iHuman Fun Idioms, iHuman Little Artists, iHuman Readers, iHuman Writing, iHuman Fantastic Friends, iHuman AI Coding, and iHuman Chinese Reading; bekids Coding, bekids Coloring, bekids Reading, bekids Puzzle, bekids Academy, and Gogo series; and Aha World and Aha Makeover. It also provides intellectually stimulating materials, including books, interactive materials, and smart devices that develop children's abilities in speaking, critical thinking, independent reading, and creativity; and Cosmicrew, a 3D comedic adventure animation series. iHuman Inc. was founded in 1996 and is based in Beijing, the People's Republic of China.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.